Amanote Research
Register
Sign In
Non–Cell Autonomous NK Cell Effects Underlie Combination Therapy Efficacy
Cancer Discovery
- United States
doi 10.1158/2159-8290.cd-rw2019-003
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Date
January 4, 2019
Authors
Unknown
Publisher
American Association for Cancer Research (AACR)
Related search
Systemic TLR2 Agonist Exposure Regulates Hematopoietic Stem Cells via Cell-Autonomous and Cell-Non-Autonomous Mechanisms
Blood Cancer Journal
Oncology
Hematology
Non-Cell-Autonomous Stimulation of Stem Cell Proliferation Following Ablation of Tcf3
Experimental Cell Research
Cell Biology
Expression of Cell Cycle Regulator Cdk2ap1 Suppresses Tumor Cell Phenotype by Non-Cell-Autonomous Mechanisms
Oral Oncology
Cancer Research
Oral Surgery
Oncology
Commentary on “Gemcitabine: Single‐Agent and Combination Therapy in Non‐Small Cell Lung Cancer”
Oncologist
Cancer Research
Medicine
Oncology
Autophagy Sustains Pancreatic Cancer Growth Through Both Cell Autonomous and Non-Autonomous Mechanisms
Cancer Discovery
Oncology
DPF Is a Cell-Density Sensing Factor, With Cell-Autonomous and Non-Autonomous Functions During Dictyostelium Growth and Development
BMC Biology
Developmental Biology
Evolution
Ecology
Genetics
Cell Biology
Molecular Biology
Biochemistry
Biological Sciences
Systematics
Structural Biology
Plant Science
Behavior
Biotechnology
Agricultural
Physiology
Regulatory Effects of Dexamethasone on NK and T Cell Immunity
Inflammopharmacology
Immunology
Pharmacology
Challenges in Bevacizumab and Gefitinib Combination Therapy for Patients With Non–Small-Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Challenges in Bevacizumab and Gefitinib Combination Therapy for Patients With Non–Small-Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary